Ataxies cérébelleuses

Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives

Domaine de recherche principal: 

Neurological and psychiatric diseases

Mots clefs: 

bases moléculaires
Physiopathologie
Parkinson
Alzheimer
Démences fronto-temporales
Ataxies cérébelleuses
Paraplégies spastiques et dystonies

Labelisation ENP: 

2007

Centre de recherche / Institut: 

Institut du Cerveau et de la Moelle épinière

Code unité de recherche: 

UMRS 1127 UMR 7225

Notre recherche est centrée sur l’étude des bases moléculaires et de la physiopathologie de différentes affections neurodégénératives. Les approches génétiques visent à cartographier des gènes responsables ou des facteurs de susceptibilité génétique de ces maladies (maladies de Parkinson et d’Alzheimer, démences fronto-temporales, ataxies cérébelleuses, paraplégies spastiques et dystonies).

Leader

Leader: 

Co leader: 

Établissements

Établissement de rattachement: 

Inserm

Établissements affiliés: 

CNRS
Université Pierre et Marie Curie

Université: 

Université Pierre et Marie Curie

École doctorale: 

ED158
Publications

publications: 

Depienne, C, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet, 5:e1000381, 2009.

Mochel, F, et al. Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA). Brain, 132:801-9, 2009.

Benajiba, L, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol, 65:470-3, 2009.

Lesage, S, et al. Parkinson?s disease-related LRRK2 G2019S mutation results for independent mutational events in humans. HMG,19:1998-2004, 2010.

Slabicki, M, et al. A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic
paraplegia. PLOS-Biol, 8:e1000408, 2010.

Nalls, MA, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 377:641-9, 2011.

Corvol, JC, et al. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. Ann Neurol, 69:111-8, 2011.

Depienne, C, et al. RAD51 haploisufficiency causes congenital mirror movements in humans. AJHG, 90:301-7, 2012.

Mochel, F, et al. Adult polyglucosan body disease: natural history and key MRI findings. Ann Neurol, 72:433-41, 2012.

Tesson, C, et al. Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spasticparaplegia. AJHG, 91:1051-64, 2012.

Lee, Y-C, Dürr, A, et al. Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol, 72:859-69, 2012.

Palminteri S, et al. Critical roles for anterior insula and dorsal striatum in punishment-based avoidance learning. Neuron, 76:998-1009,2012.

Martin, E, et al. Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia.AJHG, 92:238-44, 2013.

Chort, A, et al. Interferon-beta induces clearance of mutant ataxin-7 and improves locomotion in SCA7 knock-in mice. Brain,136:1732-45, 2013.

Depienne, C, et al. Brain white matter oedema due to ClC-2 chloride channel defi ciency: an observational analytical study. Lancet Neurol, 12:659-68, 2013.

Boukhris, A, et al. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. AJHG. 93:118-23,2013.

Lesage, S, et al. G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol, 73(4):459-71,2013.

Bertolin, G, et al. Parkin interacts with the TOM machinery to modulate mitochondrial protein import. Autophagy, 9(11):1-17,2013.

Esteves, T, et al. Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia. AJGH, 94(2):268-77,2014.

van Rheenen W, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016 Sep;48(9):1043-8. doi: 10.1038/ng.3622. Epub 2016 Jul 25.